Variation in Thermal Stability among Respiratory Syncytial Virus Clinical Isolates under Non-Freezing Conditions.

respiratory syncytial virus storage temperature thermal stability virus inactivation virus isolation

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
25 03 2022
Historique:
received: 15 02 2022
revised: 23 03 2022
accepted: 23 03 2022
entrez: 23 4 2022
pubmed: 24 4 2022
medline: 27 4 2022
Statut: epublish

Résumé

Virus isolates are not only useful for diagnosing infections, e.g., respiratory syncytial virus (RSV), but can also facilitate many aspects of practical viral studies such as analyses of antigenicity and the action mechanisms of antivirals, among others. We have been isolating RSV from clinical specimens from patients with respiratory symptoms every year since our first isolation of RSV in 1964, and isolation rates have varied considerably over the years. As collected clinical specimens are conventionally stored in a refrigerator from collection to inoculation into cells, we hypothesized that certain storage conditions or associated factors might account for these differences. Hence, we evaluated the thermal stability of a total of 64 viruses isolated from 1998 to 2018 upon storage at 4 °C and 20 °C for a defined duration. Interestingly, and contrary to our current understanding, 22 strains (34%) showed a greater loss of viability upon short-term storage at 4 °C than at 20 °C. Thirty-seven strains (57%) showed an almost equal loss, and only five strains (8%) were more stable at 4 °C than at 20 °C. This finding warrants reconsideration of the temperature for the temporary storage of clinical samples for RSV isolation.

Identifiants

pubmed: 35458409
pii: v14040679
doi: 10.3390/v14040679
pmc: PMC9029476
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Références

PLoS One. 2010 Nov 30;5(11):e15098
pubmed: 21152047
J Gen Virol. 1985 Oct;66 ( Pt 10):2111-24
pubmed: 2413163
J Clin Microbiol. 1988 Jun;26(6):1171-4
pubmed: 3290246
Microbiol Immunol. 1987;31(11):1085-95
pubmed: 3444424
Viruses. 2019 Nov 06;11(11):
pubmed: 31698728
Respiration. 2005 May-Jun;72(3):263-9
pubmed: 15942295
Rev Med Virol. 2001 Mar-Apr;11(2):103-16
pubmed: 11262529
Virol Sin. 2021 Feb;36(1):141-144
pubmed: 32458296
J Clin Virol. 2004 Oct;31(2):123-9
pubmed: 15364268
Vaccine. 1996 Oct;14(15):1417-20
pubmed: 8994316
Emerg Infect Dis. 2019 Jun;25(6):1127-1135
pubmed: 31107230
N Engl J Med. 2005 Apr 28;352(17):1749-59
pubmed: 15858184
Microbiol Immunol. 2017 Nov;61(11):497-506
pubmed: 28940687
N Engl J Med. 2009 Feb 5;360(6):588-98
pubmed: 19196675
Microbiol Immunol. 2016 Nov;60(11):801-805
pubmed: 27762443
Nat Commun. 2016 Dec 21;7:13916
pubmed: 28000669
Br J Exp Pathol. 1964 Dec;45:647-55
pubmed: 14245166
J Virol Methods. 2007 Jan;139(1):78-84
pubmed: 17052763
Am J Epidemiol. 1965 Nov;82(3):211-24
pubmed: 5854688

Auteurs

Yuki Kitai (Y)

Virus Research Center, Clinical Research Division, Sendai Medical Center, Miyagino 2-11-12, Miyagino-ku, Sendai 983-8520, Japan.
Department of Medical Microbiology, Mycology and Immunology, Tohoku University Graduate School of Medicine, Sendai 980-0872, Japan.

Ko Sato (K)

Department of Medical Microbiology, Mycology and Immunology, Tohoku University Graduate School of Medicine, Sendai 980-0872, Japan.
Department of Intelligent Network for Infection Control, Tohoku University Graduate School of Medicine, Sendai 980-0872, Japan.

Kazuya Shirato (K)

Department of Virology III, National Institute of Infectious Disease, Tokyo 208-0011, Japan.

Suguru Ohmiya (S)

Virus Research Center, Clinical Research Division, Sendai Medical Center, Miyagino 2-11-12, Miyagino-ku, Sendai 983-8520, Japan.

Oshi Watanabe (O)

Virus Research Center, Clinical Research Division, Sendai Medical Center, Miyagino 2-11-12, Miyagino-ku, Sendai 983-8520, Japan.

Tomoko Kisu (T)

Virus Research Center, Clinical Research Division, Sendai Medical Center, Miyagino 2-11-12, Miyagino-ku, Sendai 983-8520, Japan.

Reiko Ota (R)

Virus Research Center, Clinical Research Division, Sendai Medical Center, Miyagino 2-11-12, Miyagino-ku, Sendai 983-8520, Japan.

Makoto Takeda (M)

Department of Virology III, National Institute of Infectious Disease, Tokyo 208-0011, Japan.

Kazuyoshi Kawakami (K)

Department of Medical Microbiology, Mycology and Immunology, Tohoku University Graduate School of Medicine, Sendai 980-0872, Japan.
Department of Intelligent Network for Infection Control, Tohoku University Graduate School of Medicine, Sendai 980-0872, Japan.

Hidekazu Nishimura (H)

Virus Research Center, Clinical Research Division, Sendai Medical Center, Miyagino 2-11-12, Miyagino-ku, Sendai 983-8520, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH